Cited by 81Reproductive tract infections researchMicrobial infections and disease researchImmune Response and Inflammation

Chlamydial Infection of Immune Cells: Altered Function and Implications for Disease

Open access
Beagley, Kenneth, Huston, Wilhelmina M., Hansbro, Philip M., Timms, Peter·2009·Critical Reviews™ in Immunology

Abstract

Chlamydia trachomatis is an obligate intracellular bacterial pathogen that infects the genital and ocular mucosa of humans, causing infections that can lead to pelvic inflammatory disease, infertility, and blinding trachoma. C. pneumoniae is a respiratory pathogen that is the cause of 12-15% of community-acquired pneumonia. Both chlamydial species were believed to be restricted to the epithelia of the genital, ocular, and respiratory mucosa; however, increasing evidence suggests that both these pathogens can be isolated from peripheral blood of both healthy individuals and patients with inflammatory conditions such as coronary artery disease and asthma. Chlamydia can also be isolated from brain tissues of patients with degenerative neurological disorders such as Alzheimer's disease and multiple sclerosis, and also from certain lymphomas. An increasing number of in vitro studies suggest that some chlamydial species can infect immune cells, at least at low levels. These infections may alter immune cell function in a way that promotes chlamydial persistence in the host and contributes to the progression of several chronic inflammatory diseases. In this paper, we review the evidence for the growth of Chlamydia in immune cells, particularly monocytes/macrophages and dendritic cells, and describe how infection may affect the function of these cells.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1615/critrevimmunol.v29.i4.10

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Part of this paper’s reference list could not be split into single entries.

Research works printed but not linked: 94

  1. Corsaro D, Valassina M, Venditti D. Increasing diversity within Chlamydiae. Crit Rev Microbiol. 2003;29(1):37-78.
  2. Boman J, Hammerschlag MR. Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies. Clin Microbiol Rev. 2002;15(1):1-20.
  3. Stratton CW, Sriram S. Association of Chlamydia pneumoniae with central nervous system disease. Microbes Infect. 2003;5(13):1249-53.
  4. Berger L, Volp K, Mathews S, Speare R, Timms P. Chlamydia pneumoniae in a free-ranging giant barred frog (Mixophyes iteratus) from Australia. J Clin Microbiol. 1999;37(7):2378-80.
  5. Bodetti TJ, Jacobson E, Wan C, Hafner L, Pospischil A, Rose K, Timms P. Molecular evidence to support the expansion of the hostrange of Chlamydophila pneumoniae to include reptiles as well as humans, horses, koalas and amphibians. Syst Appl Microbiol. 2002;25(1):146-52.
  6. Greub G. Parachlamydia acanthamoebae, an emerg- ing agent of pneumonia. Clin Microbiol Infect. 2009;15(1):18-28.
  7. Corsaro D, Venditti D. Emerging chlamydial infec- tions. Crit Rev Microbiol. 2004;30(2):75-106.
  8. Kahane S, Metzer E, Friedman MG. Evidence that the novel microorganism 'Z' may belong to a new genus in the family Chlamydiaceae. FEMS Microbiol Lett. 1995;126(2):203-7.
  9. Kahane S, Dvoskin B, Mathias M, Friedman MG. Infection of Acanthamoeba polyphaga with Simkania negevensis and S. negevensis survival within amoebal cysts. Appl Environ Microbiol. 2001;67(10):4789-95.
  10. Goy G, Croxatto A, Greub G. Waddlia chondrophila enters and multiplies within human macrophages. Microbes Infect. 2008;10(5):556-62.
  11. Zhang JP, Stephens RS. Mechanism of C. tracho- matis attachment to eukaryotic host cells. Cell. 1992;69(5):861-9.
  12. Su H, Raymond L, Rockey DD, Fischer E, Hackstadt T, Caldwell HD. A recombinant Chlamydia trachomatis major outer membrane protein binds to heparan sulfate receptors on epithelial cells. Proc Natl Acad Sci U S A. 1996;93(20):11143-8.
  13. Ward ME, Murray A. Control mechanisms governing the infectivity of Chlamydia trachomatis for HeLa cells: mechanisms of endocytosis. J Gen Microbiol. 1984;130(7):1765-80.
  14. Hodinka RL, Davis CH, Choong J, Wyrick PB. Ultrastructural study of endocytosis of Chlamydia trachomatis by McCoy cells. Infect Immun. 1988;56(6): 1456-63.
  15. Prain CJ, Pearce JH. Ultrastructural studies on the in- tracellular fate of Chlamydia psittaci (strain guinea pig inclusion conjunctivitis) and Chlamydia trachomatis (strain lymphogranuloma venereum 434): modulation of intracellular events and relationship with endocytic mechanism. J Gen Microbiol. 1989;135(7):2107-23.
  16. Hackstadt T, Scidmore MA, Rockey DD. Lipid metabolism in Chlamydia trachomatis-infected cells: directed trafficking of Golgi-derived sphingolipids to the chlamydial inclusion. Proc Natl Acad Sci U S A. 1995;92(11):4877-81.
  17. Hoare A, Timms P, Bavoil PM, Wilson DP. Spatial constraints within the chlamydial host cell inclusion predict interrupted development and persistence. BMC Microbiol. 2008;8:5.
  18. Hybiske K, Stephens RS. Mechanisms of host cell exit by the intracellular bacterium Chlamydia. Proc Natl Acad Sci U S A. 2007;104(27):11430-5.
  19. Kuo CC, Puolakkainen M, Lin TM, Witte M, Campbell LA. Mannose-receptor positive and nega- tive mouse macrophages differ in their susceptibility to infection by Chlamydia species. Microb Pathog. 2002;32(1):43-8.
  20. Rockey DD, Fischer ER, Hackstadt T. Temporal analysis of the developing Chlamydia psittaci inclusion by use of fluorescence and electron microscopy. Infect Immun. 1996;64(10):4269-78.
  21. Hogan RJ, Mathews SA, Mukhopadhyay S, Summersgill JT, Timms P. Chlamydial persistence: beyond the bi- phasic paradigm. Infect Immun. 2004;72(4):1843-55.
  22. Koehler L, Nettelnbreker E, Hudson AP, Ott N, Gerard HC, Branigan PJ, Schumacher HR, Drommer W, Zeidler H. Ultrastructural and molecular analy- ses of the persistence of Chlamydia trachomatis (serovar K) in human monocytes. Microb Pathog. 1997;22(3):133-42.
  23. Airenne S, Surcel HM, Alakarppa H, Laitinen K, Paavonen J, Saikku P, Laurila A. Chlamydia pneu- moniae infection in human monocytes. Infect Immun. 1999;67(3):1445-9.
  24. Nanagara R, Li F, Beutler A, Hudson A, Schumacher HR Jr. Alteration of Chlamydia trachomatis biologic behavior in synovial membranes. Suppression of surface antigen production in reactive arthritis and Reiter's syndrome. Arthritis Rheum. 1995;38(10):1410-7.
  25. Skowasch D, Yeghiazar yan K, Schrempf S, Golubnitschaja O, Welsch U, Preusse CJ, Likungu JA, Welz A, Lüderitz B, Bauriedel G. Persistence of Chlamydia pneumoniae in degenerative aortic valve stenosis indicated by heat shock protein 60 homo- logues. J Heart Valve Dis. 2003;12(1):68-75.
  26. Mazzoli S, Bani A, Salvi A, Ramacciotti I, Romeo C, Bani T. In vivo evidence of Chlamydia trachomatis miniature reticulate bodies as persistence markers in pa- tients with chronic chlamydial prostatitis. Proceedings of 4th European Society for Chlamydia Research, August 20-23, 2000, Helsinki, Finland. 2000.
  27. Phillips DM, Swenson CE, Schachter J. Ultrastructure of Chlamydia trachomatis infection of the mouse oviduct. J Ultrastruct Res. 1984 Sep;88(3):244-56.
  28. Pospischil A, Borel N, Chowdhury EH, Guscetti F. Aberrant chlamydial developmental forms in the gastrointestinal tract of pigs spontaneously and experi- mentally infected with Chlamydia suis. Vet Microbiol. 2009;135(1-2):147-156.
  29. Patton DL, Askienazy-Elbhar M, Henry-Suchet J, Campbell LA, Cappuccio A, Tannous W, Wang SP, Kuo CC. Detection of Chlamydia trachomatis in fallo- pian tube tissue in women with postinfectious tubal in- fertility. Am J Obstet Gynecol. 1994;171(1):95-101.
  30. Holland SM, Hudson AP, Bobo L, Whittum-Hudson JA, Viscidi RP, Quinn TC, Taylor HR. Demonstration of chlamydial RNA and DNA during a culture- negative state. Infect Immun. 1992;60(5):2040-7.
  31. Gerard HC, Branigan PJ, Schumacher HR Jr., Hudson AP. Synovial Chlamydia trachomatis in patients with reactive arthritis/Reiter's syndrome are viable but show aberrant gene expression. J Rheumatol. 1998;25(4):734-42.
  32. Dean D, Suchland RJ, Stamm WE. Evidence for long- term cervical persistence of Chlamydia trachomatis by omp1 genotyping. J Infect Dis. 2000;182(3):909-16.
  33. Hammerschlag MR, Chirgwin K, Roblin PM, Gelling M, Dumornay W, Mandel L, Smith P, Schachter J. Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin Infect Dis. 1992;14(1):178-82.
  34. Matyszak MK, Young JL, Gaston JS. Uptake and pro- cessing of Chlamydia trachomatis by human dendritic cells. Eur J Immunol. 2002;32(3):742-51.
  35. Haranaga S, Yamaguchi H, Friedman H, Izumi S, Yamamoto Y. Chlamydia pneumoniae infects and multiplies in lymphocytes in vitro. Infect Immun. 2001;69(12):7753-9.
  36. Yong EC, Chi EY, Kuo CC. Differential antimicrobial activity of human mononuclear phagocytes against the human biovars of Chlamydia trachomatis. J Immunol. 1987;139(4):1297-302.
  37. Gerard HC, Kohler L, Branigan PJ, Zeidler H, Schumacher HR, Hudson AP. Viability and gene expression in Chlamydia trachomatis during persis- tent infection of cultured human monocytes. Med Microbiol Immunol. 1998;187(2):115-20.
  38. Schmitz E, Nettelnbreker E, Zeidler H, Hammer M, Manor E, Wollenhaupt J. Intracellular persis- tence of chlamydial major outer-membrane protein, lipopolysaccharide and ribosomal RNA after non- productive infection of human monocytes with Chlamydia trachomatis serovar K. J Med Microbiol. 1993;38(4):278-85.
  39. Schrader S, Klos A, Hess S, Zeidler H, Kuipers JG, Rihl M. Expression of inflammatory host genes in Chlamydia trachomatis-infected human monocytes. Arthritis Res Ther. 2007;9(3):R54. Volume 29 Number 4
  40. Jendro MC, Deutsch T, Korber B, Kohler L, Kuipers JG, Krausse-Opatz B, Westermann J, Raum E, Zeidler H. Infection of human monocyte-derived macrophages with Chlamydia trachomatis induces apoptosis of T cells: a potential mechanism for persistent infection. Infect Immun. 2000;68(12):6704-11.
  41. Jendro MC, Fingerle F, Deutsch T, Liese A, Kohler L, Kuipers JG, Raum E, Martin M, Zeidler H. Chlamydia trachomatis-infected macrophages induce apoptosis of activated T cells by secretion of tumor necrosis factor-alpha in vitro. Med Microbiol Immunol. 2004;193(1):45-52.
  42. Poikonen K, Lajunen T, Silvennoinen-Kassinen S, Paldanius M, Leinonen M, Saikku P. Susceptibility of human monocyte-macrophages to Chlamydia pneumoniae infection in vitro is highly variable and associated with levels of soluble CD14 and C. pneumoniae IgA and human HSP-IgG antibodies in serum. Scand J Immunol. 2008;67(3):279-84.
  43. Geng Y, Shane RB, Berencsi K, Gonczol E, Zaki MH, Margolis DJ, Trinchieri G, Rook AH. Chlamydia pneumoniae inhibits apoptosis in human peripheral blood mononuclear cells through induction of IL-10. J Immunol. 2000;164(10):5522-9.
  44. Yamaguchi H, Haranaga S, Widen R, Friedman H, Yamamoto Y. Chlamydia pneumoniae infection in- duces differentiation of monocytes into macrophages. Infect Immun. 2002;70(5):2392-8.
  45. Kaukoranta-Tolvanen SS, Teppo AM, Laitinen K, Saikku P, Linnavuori K, Leinonen M. Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response. Microb Pathog. 1996;21(3):215-21.
  46. Klos A, Thalmann J, Peters J, Gerard HC, Hudson AP. The transcript profile of persistent Chlamydophila (Chlamydia) pneumoniae in vitro depends on the means by which persistence is induced. FEMS Microbiol Lett. 2009;291(1):120-6.
  47. Hearst JE, Warr GA, Jakab GJ. Characterization of murine lung and peritoneal macrophages. J Reticuloendothel Soc. 1980;27(5):443-54.
  48. Nakajo MN, Roblin PM, Hammerschlag MR, Smith P, Nowakowski M. Chlamydicidal activ- ity of human alveolar macrophages. Infect Immun. 1990;58(11):3640-4.
  49. Redecke V, Dalhoff K, Bohnet S, Braun J, Maass M. Interaction of Chlamydia pneumoniae and human alveolar macrophages: infection and inflammatory response. Am J Respir Cell Mol Biol. 1998;19(5): 721-7.
  50. Gaydos CA, Summersgill JT, Sahney NN, Ramirez JA, Quinn TC. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immun. 1996;64(5):1614-20.
  51. Mpiga P, Ravaoarinoro M. Effects of sustained antibi- otic bactericidal treatment on Chlamydia trachomatis- infected epithelial-like cells (HeLa) and monocyte-like cells (THP-1 and U-937). Int J Antimicrob Agents. 2006;27(4):316-24.
  52. Numazaki K, Suzuki K, Chiba S. Replication of Chlamydia trachomatis and C. pneumoniae in the human monocytic cell line U-937. J Med Microbiol. 1995;42(3):191-5.
  53. Yamaguchi H, Haranaga S, Friedman H, Moor JA, Muffly KE, Yamamoto Y. A Chlamydia pneumoniae infection model using established human lymphocyte cell lines. FEMS Microbiol Lett. 2002;216(2):229-34.
  54. Heinemann M, Susa M, Simnacher U, Marre R, Essig A. Growth of Chlamydia pneumoniae induces cytokine production and expression of CD14 in a human mono- cytic cell line. Infect Immun. 1996;64(11):4872-5.
  55. Shemer-Avni Y, Wallach D, Sarov I. Inhibition of Chlamydia trachomatis growth by recombinant tumor necrosis factor. Infect Immun. 1988;56(9):2503-6.
  56. Wahl C, Oswald F, Simnacher U, Weiss S, Marre R, Essig A. Survival of Chlamydia pneumoniae-infected Mono Mac 6 cells is dependent on NF-kappaB bind- ing activity. Infect Immun. 2001;69(11):7039-45.
  57. Paland N, Bohme L, Gurumurthy RK, Maurer A, Szczepek AJ, Rudel T. Reduced display of tumor ne- crosis factor receptor I at the host cell surface supports infection with Chlamydia trachomatis. J Biol Chem. 2008 Mar 7;283(10):6438-48.
  58. Shirey KA, Carlin JM. Chlamydiae modulate gamma interferon, interleukin-1 beta, and tumor necrosis factor alpha receptor expression in HeLa cells. Infect Immun. 2006;74(4):2482-6.
  59. Kuo CC. Immediate cytotoxicity of Chlamydia tra- chomatis for mouse peritoneal macrophages. Infect Immun. 1978;20(3):613-8.
  60. Kuo CC. Cultures of Chlamydia trachomatis in mouse peritoneal macrophages: factors affecting organism growth. Infect Immun. 1978;20(2):439-45.
  61. Wy r ic k P B, Brownr idge EA. Grow th of Chlamydia psittaci in macrophages. Infect Immun. 1978;19(3):1054-60.
  62. Wyrick PB, Brownridge EA, Ivins BE. Interaction of Chlamydia psittaci with mouse peritoneal mac- rophages. Infect Immun. 1978;19(3):1061-7.
  63. Haranaga S, Yamaguchi H, Ikejima H, Friedman H, Yamamoto Y. Chlamydia pneumoniae infec- tion of alveolar macrophages: a model. J Infect Dis. 2003;187(7):1107-15.
  64. Rothfuchs AG, Gigliotti D, Palmblad K, Andersson U, Wigzell H, Rottenberg ME. IFN-alpha beta- dependent, IFN-gamma secretion by bone marrow- derived macrophages controls an intracellular bacterial infection. J Immunol. 2001 Dec 1;167(11):6453-61.
  65. Trumstedt C, Eriksson E, Lundberg AM, Yang TB, Yan ZQ, Wigzell H, Rottenberg ME. Role of IRAK4 and IRF3 in the control of intracellular in- fection with Chlamydia pneumoniae. J Leukoc Biol. 2007;81(6):1591-8.
  66. Rothfuchs AG, Trumstedt C, Wigzell H, Rottenberg ME. Intracellular bacterial infection-induced IFN- gamma is critically but not solely dependent on Toll-like receptor 4-myeloid differentiation factor 88-IFN-alpha beta-STAT1 signaling. J Immunol. 2004;172(10):6345-53.
  67. Kalayoglu MV, Perkins BN, Byrne GI. Chlamydia pneumoniae-infected monocytes exhibit increased adherence to human aortic endothelial cells. Microbes Infect. 2001;3(12):963-9.
  68. Kaul R, Wenman WM. Chlamydia pneumoniae fa- cilitates monocyte adhesion to endothelial and smooth muscle cells. Microb Pathog. 2001;30(3):149-55.
  69. May AE, Redecke V, Gruner S, Schmidt R, Massberg S, Miethke T, Ryba B, Prazeres da Costa C, Schömig A, Neumann FJ. Recruitment of Chlamydia pneumoniae-infected macrophages to the carotid artery wall in noninfected, nonatherosclerotic mice. Arterioscler Thromb Vasc Biol. 2003 May 1;23(5): 789-94.
  70. Takaoka N, Campbell LA, Lee A, Rosenfeld ME, Kuo CC. Chlamydia pneumoniae infection increases adherence of mouse macrophages to mouse endothelial cells in vitro and to aortas ex vivo. Infect Immun. 2008;76(2):510-4.
  71. Azenabor AA, Job G, Adedokun OO. Chlamydia pneumoniae infected macrophages exhibit enhanced plasma membrane fluidity and show increased adherence to endothelial cells. Mol Cell Biochem. 2005;269(1-2):69-84.
  72. Hatch GM, McClarty G. C. trachomatis-infection accelerates metabolism of phosphatidylcholine derived from low density lipoprotein but does not affect phosphatidylcholine secretion from hepatocytes. BMC Microbiol. 2004 Feb 17;4:8.
  73. Cocchiaro JL, Kumar Y, Fischer ER, Hackstadt T, Valdivia RH. Cytoplasmic lipid droplets are translo- cated into the lumen of the Chlamydia trachomatis parasitophorous vacuole. Proc Natl Acad Sci U S A. 2008 Jul 8;105(27):9379-84.
  74. Heuer D, Lipinski AR, Machuy N, Karlas A, Wehrens A, Siedler F, Brinkmann V, Meyer TF. Chlamydia causes fragmentation of the Golgi compartment to ensure reproduction. Nature. 2009;457(7230):731-5.
  75. MacIntyre A, Abramov R, Hammond CJ, Hudson AP, Arking EJ, Little CS, Appelt DM, Balin BJ. Chlamydia pneumoniae infection promotes the transmigration of monocytes through human brain endothelial cells. J Neurosci Res. 2003;71(5):740-50.
  76. Kalayoglu MV, Byrne GI. Induction of macrophage foam cell formation by Chlamydia pneumoniae. J Infect Dis. 1998;177(3):725-9.
  77. Kalayoglu MV, Byrne GI. A Chlamydia pneumoniae component that induces macrophage foam cell forma- tion is chlamydial lipopolysaccharide. Infect Immun. 1998;66(11):5067-72.
  78. Cao F, Castrillo A, Tontonoz P, Re F, Byrne GI. Chlamydia pneumoniae-induced macrophage foam cell formation is mediated by toll-like receptor 2. Infect Immun. 2007;75(2):753-9.
  79. Chen S, Sorrentino R, Shimada K, Bulut Y, Doherty TM, Crother TR, Arditi M. Chlamydia pneumoniae-induced foam cell formation requires MyD88-dependent and -independent signaling and is reciprocally modulated by liver X receptor activation. J Immunol. 2008;181(10):7186-93.
  80. He P, Mei C, Cheng B, Liu W, Wang Y, Wan J. Chlamydia pneumoniae induces macrophage-derived foam cell formation by up-regulating acyl-coenzyme A: cholesterol acyltransferase 1. Microbes Infect. 2008;11(2):157-63.
  81. Chang TY, Chang CC, Cheng D. Acyl-coenzyme A:cholesterol acyltransferase. Annu Rev Biochem. 1997;66:613-38.
  82. Gervassi A, Alderson MR, Suchland R, Maisonneuve JF, Grabstein KH, Probst P. Differential regulation of inflammatory cytokine secretion by human dendritic cells upon Chlamydia trachomatis infection. Infect Immun. 2004;72(12):7231-9.
  83. Wittkop U, Krausse-Opatz B, Gust TC, Kirsch T, Hollweg G, Kohler L, Zenke M, Gérard HC, Hudson AP, Zeidler H, Wagner AD. Fate of Chlamydophila pneumoniae in human monocyte-derived den- dritic cells: long lasting infection. Microb Pathog. 2006;40(3):101-9.
  84. Rey-Ladino J, Jiang X, Gabel BR, Shen C, Brunham RC. Survival of Chlamydia muridarum within dendritic cells. Infect Immun. 2007;75(8): 3707-14.
  85. Kaiko GE, Phipps S, Hickey DK, Lam CE, Hansbro PM, Foster PS, Beagley KW. Chlamydia muridarum infection subverts dendritic cell function to promote Th2 immunity and airways hyperreactivity. J Immunol. 2008;180(4):2225-32.
  86. Wittkop U, Peppmueller M, Njau F, Leibold W, Klos A, Krausse-Opatz B, Hudson AP, Zeidler H, Haller H, Wagner AD. Transmission of Chlamydophila pneumoniae from dendritic cells to macrophages does not require cell-to-cell contact in vitro. J Microbiol Methods. 2008;72(3):288-95.
  87. Kis Z, Treso B, Burian K, Endresz V, Pallinger E, Nagy A, Toth A, Takacs M, Falus A, Gonczol E. Expression of bacterial genes and induction of INF- gamma in human myeloid dendritic cells during persistent infection with Chlamydophila pneumo- niae. FEMS Immunol Med Microbiol. 2008;52(3): 324-34.
  88. Jiang X, Shen C, Rey-Ladino J, Yu H, Brunham RC. Characterization of murine dendritic cell line JAWS II and primary bone marrow-derived dendritic cells in Chlamydia muridarum antigen presentation and induction of protective immunity. Infect Immun. 2008;76(6):2392-401.
  89. Su H, Messer R, Whitmire W, Fischer E, Portis JC, Caldwell HD. Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable Chlamydiae. J Exp Med. 1998 Sep 7;188(5):809-18.
  90. Igietseme JU, Ananaba GA, Bolier J, Bowers S, Moore T, Belay T, Eko FO, Lyn D, Black CM. Suppression of endogenous IL-10 gene expression in dendritic cells enhances antigen presentation for specific Th1 induction: potential for cellular vaccine development. J Immunol. 2000;164(8):4212-9.
  91. Lu H, Zhong G. Interleukin-12 production is required for chlamydial antigen-pulsed dendritic cells to induce Volume 29 Number 4 protection against live Chlamydia trachomatis infec- tion. Infect Immun. 1999;67(4):1763-9.
  92. Rey-Ladino J, Koochesfahani KM, Zaharik ML, Shen C, Brunham RC. A live and inactivated Chlamydia trachomatis mouse pneumonitis strain induces the maturation of dendritic cells that are phenotypi- cally and immunologically distinct. Infect Immun. 2005;73(3):1568-77.
  93. Zaharik ML, Nayar T, White R, Ma C, Vallance BA, Straka N, Jiang X, Rey-Ladino J, Shen C, Brunham RC. Genetic profiling of dendritic cells exposed to live-or ultraviolet-irradiated Chlamydia muridarum reveals marked differences in CXC chemokine profiles. Immunology. 2007;120(2):160-72.
  94. Karunakaran KP, Rey-Ladino J, Stoynov N, Berg K, Shen C, Jiang X, Gabel BR, Yu H, Foster LJ, Brunham RC. Immunoproteomic discovery of novel T cell antigens from the obligate intracellular pathogen Chlamydia. J Immunol. 2008;180(4):2459-65. 100. Yu H, Jiang X, Shen C, Karunakaran KP, Brunham RC. Novel Chlamydia muridarum T cell anti- gens induce protective immunity against lung and genital tract infection in murine models. J Immunol. 2009;182(3):1602-8. 101. Hansbro PM, Beagley KW, Horvat JC, Gibson PG. Role of atypical bacterial infection of the lung in predisposition/protection of asthma. Pharmacol Ther. 2004;101(3):193-210. 102. Horvat JC, Beagley KW, Wade MA, Preston JA, Hansbro NG, Hickey DK, Kaiko GE, Gibson PG, Foster PS, Hansbro PM. Neonatal chlamydial infection induces mixed T-cell responses that drive allergic airway disease. Am J Respir Crit Care Med. 2007;176(6):556-64. 103. Register KB, Morgan PA, Wyrick PB. Interaction between Chlamydia spp. and human polymor- phonuclear leukocytes in vitro. Infect Immun. 1986;52(3):664-70. 104. Yong EC, Chi EY, Chen WJ, Kuo CC. Degradation of Chlamydia trachomatis in human polymor- phonuclear leukocytes: an ultrastructural study of peroxidase-positive phagolysosomes. Infect Immun. 1986;53(2):427-31. 105. van Zandbergen G, Gieffers J, Kothe H, Rupp J, Bollinger A, Aga E, Klinger M, Brade H, Dalhoff K, Maass M, Solbach W, Laskay T. Chlamydia pneumoniae multiply in neutrophil granulocytes and delay their spontaneous apoptosis. J Immunol. 2004;172(3):1768-76. 106. Rank RG, Whittimore J, Bowlin AK, Dessus-Babus S, Wyrick PB. Chlamydiae and polymorphonuclear leukocytes: unlikely allies in the spread of chla- mydial infection. FEMS Immunol Med Microbiol. 2008;54(1):104-13. 107. Martin RJ, Kraft M, Chu HW, Berns EA, Cassell GH. A link between chronic asthma and chronic infection. J Allergy Clin Immunol. 2001;107(4): 595-601. 108. Oksaharju A, Lappalainen J, Tuomainen AM, Pussinen PJ, Puolakkainen M, Kovanen PT, Lindstedt KA. Proatherogenic lung and oral pathogens induce an inflammatory response in human and mouse mast cells. J Cell Mol Med. 2009;13(1):103-13. 109. Fainardi E, Castellazzi M, Seraceni S, Granieri E, Contini C. Under the microscope: focus on Chlamydia pneumoniae infection and multiple sclerosis. Curr Neurovasc Res. 2008;5(1):60-70. 110. Balin BJ, Little CS, Hammond CJ, Appelt DM, Whittum-Hudson JA, Gerard HC, Hudson AP. Chlamydophila pneumoniae and the etiology of late-onset Alzheimer's disease. J Alzheimers Dis. 2008;13(4):371-80. 111. Boelen E, Steinbusch HW, Pronk I, Grauls G, Rennert P, Bailly V, Bruggeman CA, Stassen FR. Inflammatory responses following Chlamydia pneumoniae infection of glial cells. Eur J Neurosci. 2007;25(3):753-60. 112. Boelen E, Steinbusch HW, van der Ven AJ, Grauls G, Bruggeman CA, Stassen FR. Chlamydia pneumoniae infection of brain cells: an in vitro study. Neurobiol Aging. 2007;28(4):524-32. 113. Appelt DM, Roupas MR, Way DS, Bell MG, Albert EV, Hammond CJ, Balin BJ. Inhibition of apoptosis in neuronal cells infected with Chlamydophila (Chlamydia) pneumoniae. BMC Neurosci. 2008;9:13. 114. Ikejima H, Friedman H, Yamamoto Y. Chlamydia pneumoniae infection of microglial cells in vitro: a model of microbial infection for neurological disease. J Med Microbiol. 2006;55(Pt 7):947-52. 115. Bar-Or A, Oliveira EM, Anderson DE, Hafler DA. Molecular pathogenesis of multiple sclerosis. J Neuroimmunol. 1999;100(1-2):252--9. 116. Rosenberg GA. Matrix metalloproteinases in neuroin- flammation. Glia. 2002;39(3):279-91. 117. Dreses-Werringloer U, Gerard HC, Whittum- Hudson JA, Hudson AP. Chlamydophila (Chlamydia) pneumoniae infection of human astrocytes and microglia in culture displays an active, rather than a persistent, phenotype. Am J Med Sci. 2006;332(4): 168-74. 118.

Cited by

Sorted by citations

Authors
Beagley, K., Huston, W. M., Hansbro, P. M., & Timms, P.
Affiliations
  • Queensland University of Technology (AU)
  • University of Technology Sydney (AU)
Venue
Critical Reviews™ in Immunology
Publisher
Begell House
Published
2009
Volume
29
Issue
4
Pages
275-305
ISSN
  • 0197-3355 (ISSN-L)
  • 2162-6472
OpenAlex
W1522243508
Cited by
81
References
0
Citations by year
2025: 1 · 2024: 5 · 2023: 7 · 2022: 3 · 2021: 1 · 2020: 5 · 2019: 6 · 2018: 4 · 2017: 2 · 2016: 3 · 2015: 7 · 2014: 7 · 2013: 12 · 2012: 9
FWCI
5.49
Type
journal article
Language
en
Open access
Locations
  • Critical Reviews in Immunology (publishedVersion)
  • PubMed (publishedVersion)
  • QUT ePrints (Queensland University of Technology) (submittedVersion)
  • USC Research Bank (University of the Sunshine Coast) (submittedVersion)
  • Institute of Health and Biomedical Innovation
Topics
  • Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
  • Life Sciences › Immunology and Microbiology › Microbiology › Microbial infections and disease research
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
Keywords
Chlamydia trachomatis, Chlamydia pneumoniae, monocytes, macrophages, dendritic cells, chlamydial persistence, chronic inflammation, Alzheimer's disease, multiple sclerosis, lymphoma, pelvic inflammatory disease, trachoma, community-acquired pneumonia
MeSH terms
Animals, Chlamydia, Chlamydia Infections, Dendritic Cells, Biological Evolution, Humans, Inflammation, Macrophages, Monocytes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review